Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14018852 | 1.00 | DNM1 (0.37) | DNM1MAOBMAPTTP53TDP1 | |
| SCHEMBL4851091 | 1.00 | DNM1 (0.37) | DNM1MAOBMAPTTP53TDP1 | |
| SCHEMBL14018909 | 0.89 | TDP1 (0.33) | TDP1L3MBTL1KDM4E | |
| SCHEMBL14017688 | 0.89 | DNM1 (0.39) | DNM1MAOBMAPTTP53TDP1 | |
| SCHEMBL14017685 | 0.84 | MAOB (0.40) | DNM1MAOBMAPTTP53TDP1 | |
| SCHEMBL14488715 | 0.83 | CES2 (0.34) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL2806467 | 0.83 | LMNA (0.40) | MAPTTP53TDP1POLBALDH1A1 | |
| SCHEMBL2806471 | 0.83 | LMNA (0.40) | MAPTTP53TDP1POLBALDH1A1 | |
| SCHEMBL14163400 | 0.82 | DNM1 (0.46) | DNM1MAOBMAPTTP53TDP1 | |
| Malonic Acid SCHEMBL2415013 | 0.80 | LMNA (0.39) | MAPTTP53TDP1POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7439380-B2 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | L'OREAL (FR) | 2008-10-21 | — | — | US | disclosed |
| US-20070213548-A1 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | L'OREAL | 2007-09-13 | — | — | US | disclosed |
| US-7229610-B2 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | L'OREAL (FR) | 2007-06-12 | — | — | US | disclosed |
| US-20050129636-A1 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | L'OREAL (FR) | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213548-A1 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | XPA, ERCC4, DCLRE1A | DNM1 4704/4885MAOB 990/4885MAPT 3385/4885 |
| US-20050129636-A1 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | XPA, ERCC4, DCLRE1A | DNM1 4704/4885MAOB 990/4885MAPT 3385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.